Biotech Values

[drbio45]

there has never been a stroke trial with a 50 percent placebo response rate

renovis had a 35 percent rate

that is what happens when you do small trials on the cheap.

you run larger trials to remove issues like this

they didn't even check reperfusion rates, which they did do in the phase 2.

Paion spent more on their phase 2 trial than Forest paid for the phase 2/3. stupidity